CNBC's Bertha Coombs asks President Trump and his team at the White House's announcement on lower prices for Eli Lilly and ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

Pfizer seals the deal with Metsera for $10 billion after Novo Nordisk bowed out; President Donald Trump welcomes executives ...

The Trump administration’s recent deal with drug manufacturers to lower the cost of popular GLP-1 weight-loss medications is ...

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...

At a White House event Thursday, President Trump announced deals with drug makers Novo Nordisk and Eli Lilly to offer their ...

Brooks Nader has kept it candid when it comes to her use of weight-loss drugs. The Sports Illustrated Swimsuit model has been ...

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth ...

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

Patients with type 2 diabetes who use GLP-1 receptor agonists have a significantly lower risk for lung cancer than those who ...